ABPI statement on the Northern Ireland Protocol

The UK Government has published a Command Paper: Northern Ireland Protocol: the way forward

We urgently need the UK and the EU to agree a way forward on how the Protocol will work for patients in Northern Ireland, and provide companies with the time, support, and assurances they need Richard Torbett

In a statement, Richard Torbett, Chief Executive, the Association of the British Pharmaceutical Industry, said:

"It’s clear that medicines remain high on the agenda, but our issues still need to be resolved. We urgently need the UK and the EU to agree a way forward on how the Protocol will work for patients in Northern Ireland, and provide companies with the time, support, and assurances they need.

“With time running out, it is critical that all possible solutions are fully explored and considered together with stakeholders, in the best interests of patients.”

 

TAGS
  • Northern Ireland

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.